SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-194653
Filing Date
2017-06-05
Accepted
2017-06-05 16:31:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d404406d424b5.htm 424B5 506904
2 GRAPHIC g404406g61r59.jpg GRAPHIC 48366
  Complete submission text file 0001193125-17-194653.txt   574753
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-200452 | Film No.: 17891575
SIC: 2834 Pharmaceutical Preparations